Entrepreneur behind cancer app gains foothold with the EU - and a possible double digit million kroner grant

Entrepeneur company Miiskin has received a grant of DKK 374.000 (USD 55,000), paving the way for another payment of DKK 19 million (USD 2.8 million). The goal is to lead the global market, and the money will be spent on further developing the company's app, which is used to spot cancer.

Jon Friis, CEO of Miiskin Photo: Miiskin / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles